NIO vs RNAZ · rev $12.51B vs $5.1M cap
Nio Inc Class A ADR (NIO) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
RNAZ does not have a complete income-statement cache yet.
NIO currently screens at market cap $7.61B. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the NIO and RNAZ stock pages for the full models.
Not investment advice.